Introduction {#sec1-1}
============

Dengue, a common mosquito-borne viral disease, occurs in tropical and subtropical countries especially South and Southeast Asia countries, the Caribbean, Central, and South America, and Africa. Dengue virus (DENV) infection is the most rapidly spreading disease in the world with a 30-fold increase in incidence in the past 50 years.\[[@ref1]\] The first dengue fever in India was reported in 1956 from Vellore and the first dengue hemorrhagic fever occurred in Calcutta in 1963.\[[@ref2]\] Dengue is caused by one of the four serotypes of DEVN (DENV-1--DENV-4) belonging to the family *Flaviviridae*.\[[@ref3]\] All the four serotypes of the virus have been in circulation and documented in Tamil Nadu.\[[@ref4]\] Dengue fever is an acute febrile illness with frontal headache, retro-ocular pain, muscle pain, joint pain, and rash, even though other signs and symptoms could also be present (such as lymphadenopathy, petechiale, nausea, hepatomegaly, and different types of hemorrhagic manifestations).\[[@ref5]\] Atypical manifestations are rare and include encephalopathy, encephalitis, seizures, hepatocellular damage, acalculous cholecystitis, myocarditis, pericardial effusion, and severe gastrointestinal hemorrhage.\[[@ref6][@ref7]\] The clinical presentation in dengue depends on the virus strain, as well as the age and immune status of the host.\[[@ref3]\] This study aims to elucidate the salient clinical feature and laboratory findings of serologically confirmed cases of dengue fever. The elucidation of clinical profile is very important for primary care, management, and thus crucial for saving life.

Aim of the Study {#sec1-2}
================

This study aims to study the clinical profile and atypical manifestations in patients with dengue fever.

Materials and Methods {#sec1-3}
=====================

This retrospective observational study was conducted during the period from July 2011 to December 2018 at Sri Muthukumaran Medical College, Hospital and Research Institute, Chennai, India. Informed consent was taken from each patient and the study was approved by Institutional Ethical Committee (obtained on 23.12.2016 (46/IECs)). Serum samples were collected from clinically suspected cases of dengue and were confirmed by NS1 antigen, IgM, and IgG antibody by ELISA (J. Mitra and Co. Pvt. Ltd.). A detailed history was taken and careful clinical examination was performed on all the positive cases. Hematological parameters such as platelet count, hemoglobin, hematocrit (HCT) levels, complete blood count (CBC), and white blood cell count (WBC) were also recorded.

Observation {#sec1-4}
===========

During the study period, a total of 2502 patients were suspected to have dengue fever, out of which 464 (18.5%) samples were found to be positive. In our study population, the highest numbers of dengue-positive cases were screened in the year 2017 (74.8%), followed by 2013 (27.7%) and 2016 (18.8%) as shown in \[[Table 1](#T1){ref-type="table"}\]. A majority of the cases were males 268 (57.7%) and females were 196 (42.2%). About 45% of positive cases belonged to adult age groups (18--44 years) followed by younger age group \<18 years (30%) \[[Table 2](#T2){ref-type="table"}\]. Fever was the most common clinical presentation which was found among all the patients, followed by headache (78.4%), myalgia (61.2%), body pain (49.3%), vomiting (40%), joint pain (31%), dry cough (19%), nausea (13.5%), abdominal pain (8%), diarrhea (5.6%), retro-orbital pain (4%), burning micturition (2.5%), and rashes (0.6%) \[[Table 3](#T3){ref-type="table"}\]. In this study, 90 (19.3%) patients had atypical manifestations. Hepatomegaly \[32 (7%)\] was the most common manifestation, followed by splenomegaly \[23 (5%)\], bradycardia \[18 (4%)\], meningitis \[6 (1.2%)\], hemoptysis \[5 (1%)\], acalculous cholecystitis \[4 (0.8%)\], and acute pancreatitis \[2 (0.4%)\] \[[Table 4](#T4){ref-type="table"}\]. The majority of the patients were positive for NS~1~ Ag 290 (62.5%) followed by IgG 80 (17.2%), IgM 53 (11.4%), and IgM + IgG 41 (9%) as shown in \[[Table 5](#T5){ref-type="table"}\]. Raised HCT was found in 29 (6.2%) and leukopenia (\<4000/mm^3^) was found in 77 (16.5%) patients. Thrombocytopenia was observed in 179 (38.5%) cases \[[Table 6](#T6){ref-type="table"}\].

###### 

Year-wise distribution of dengue cases during the study period

  Year    Total no. of cases   Positive cases
  ------- -------------------- ----------------
  2011    346                  9 (2.6%)
  2012    463                  25 (5.3%)
  2013    457                  127 (27.7%)
  2014    342                  72 (21%)
  2015    460                  85 (18.4%)
  2016    90                   17 (18.8%)
  2017    151                  113 (74.8%)
  2018    193                  16 (8.2%)
  Total   2502                 464 (18.5%)

###### 

Age and sex-wise distribution of dengue cases (*n*=464)

  Age groups (years)   Males         Females       Total
  -------------------- ------------- ------------- -----------
  \<18                 81            57            138 (30%)
  18-44                118           89            207 (45%)
  45-60                47            35            82 (18%)
  \>60                 22            15            37 (8%)
  Total                268 (57.7%)   196 (42.2%)   

###### 

Clinical features of *dengue*-positive cases (*n*=464)

  Clinical features     No. of cases (%)
  --------------------- ------------------
  Fever                 439 (95%)
  Headache              364 (78.4%)
  Myalgia               284 (61.2%)
  Body pain             229 (49.3%)
  Vomiting              186 (40%)
  Joint pain            144 (31%)
  Dry cough             89 (19.1%)
  Nausea                63 (13.5%)
  Abdominal pain        38 (8.1%)
  Diarrhea              26 (5.6%)
  Retro-orbital pain    19 (4%)
  Burning micturition   12 (2.5%)
  Rashes                03 (0.6%)

###### 

Atypical clinical manifestations in dengue patients (*n*=90)

  Clinical features          No. of cases (%)
  -------------------------- ------------------
  Hepatomegaly               32 (7%)
  Splenomegaly               23 (5%)
  Bradycardia                18 (4%)
  Meningitis                 6 (1.2%)
  Hemoptysis                 05 (1%)
  Acalculous cholecystitis   04 (0.8%)
  Acute pancreatitis         2 (0.4%)
  Total                      90 (19.3%)

###### 

Serological marker distribution of dengue cases

  Total no. of patients (*n*=464)   Dengue-specific marker                             
  --------------------------------- ------------------------ ------------ ------------ ---------
  Dengue-positive cases             290 (62.5%)              53 (11.4%)   80 (17.2%)   41 (9%)

###### 

Hematological parameters of dengue-positive cases (*n*=464)

  Investigation                        No. of cases (%)
  ------------------------------------ ------------------
  Thrombocytopenia (\<150,000/mm^3^)   179 (38.5%)
  Leucopenia (\<4000/mm^3^)            77 (16.5%)
  Raised hematocrit                    29 (6.2%)

Discussion {#sec1-5}
==========

Dengue is emerging as a major health problem and regular outbreaks of dengue infection have been occurring throughout India.\[[@ref8][@ref9]\] The provision of adequate care to patients with suspected dengue in primary care settings requires effective clinical evaluation, laboratory testing, and qualified professionals who know how to recognize warning signs and give appropriate guidance to prevent expended dengue.\[[@ref10]\] Rapid urbanization, globalization, increasing population, poor solid waste, and water management have given rise to new habitats for mosquito breeding thereby increasing the number of cases and deaths.\[[@ref1][@ref11]\] The identification of dengue cases is possible by distinct clinical features. Studies describe that atypical manifestations in dengue fever are multisystemic and multifaceted with organ involvement, such as liver, brain, heart, kidney, and central nervous system.\[[@ref12]\] In this study, we investigated the different clinical profile and atypical manifestations.

Incidences of dengue positivity were increasing for the past few years. In our study, we found that the highest number of dengue-positive cases was reported in the year 2017 (74.8%), 2013 (27.7%), and 2016 (18.8%), which were similar to that of previous studies reported.\[[@ref13][@ref14]\] Studies revealed that the majority of the cases were in the age group of 15--44 years, followed by other groups. In this study, males \[268 (57.7%)\] were predominant than females \[196 (42.2%)\]. These findings well correlate with previous studies.\[[@ref15]\] Fever was the most common clinical presentation which was found among all the presenting patients (100%). Headache (78%) and myalgia (61%) were seen in the majority of cases, followed by joint pain (31%), dry cough (19%), abdominal pain (8%), diarrhea (5.6%), vomiting (32%), and nausea (14%) which is concordant with the study by Hasan SR *et al*.\[[@ref16]\]

Atypical symptoms have been observed in this study, which is low compared with previous study done by Nagarajan *N* *et al*.\[[@ref17]\] Retro-orbital pain as a cardinal feature of dengue fever was seen in few (4%), of our patients, while Denys EF *et al*. had reported 16.1%.\[[@ref18]\] Burning micturition (8%), hemoptysis (2%), and rashes (0.2%) were not frequent in our study when compared with other studies.\[[@ref19]\] Hepatomegaly is highly specific for the development of both dengue hemorrhagic fever and dengue shock syndrome. In our study, 31 (7%) patients had hepatomegaly which correlates with a previous study done by Row EK *et al*.\[[@ref20]\] In our study, splenomegaly was 5% which is concordant with a previous study reported by Anurag Prasad *et al*.\[[@ref21]\] Other less common atypical manifestations were bradycardia \[18 (4%)\], meningitis \[6 (1.2%)\], hemoptysis \[5 (1%)\], acalculous cholecystitis \[4 (0.8%)\], and acute \[pancreatitis 2 (0.4%)\]. This differs from other studies where bradycardia, meningitis, hemoptysis, and acalculous cholecystitis were detected in higher percentage of confirmed dengue fever.\[[@ref22][@ref23][@ref24][@ref25]\]

Out of 2038 samples of clinically suspected dengue cases, 464 (23%) were found to be positive by ELISA. The majority of the samples were found positive for NS1 antigen 290 (63%), which indicates high sensitivity of the test for early diagnosis of disease, followed by IgG and IgM antibodies, which is similar to a study conducted by Anand *et al*.\[[@ref26]\] In our study, thrombocytopenia was present in 179 (39%) patients \<150,000/mm^3^, which is slightly less than the study conducted by Ahmed NH *et al*. Recent studies have established HCT \> 40% as a prognostic factor for severe dengue.\[[@ref26][@ref27][@ref28][@ref29]\] In our study, we have found raised HCT in 29 (6.2%) patients. Low leucocyte count may be due to virus-induced inhibition of myeloid progenitor cells or due to destruction.\[[@ref30]\] We found that 11% had leucocyte count \<5000, almost similar to a study by Chaloemwong J *et al*.\[[@ref31]\] An understanding of the course of disease progression, risk factors, recognition of the warning signs, and look out for clinical problems during the different phases of the disease will enable primary care physicians to manage dengue fever in an appropriate and timely manner to reduce morbidity and mortality.\[[@ref32]\] Primary care physician should impart health education about dengue fever to the rural community regularly, through health camps or interpersonal communication based on health awareness programs.\[[@ref33]\] Thus, atypical presentations should prompt us to investigate for dengue especially during ongoing epidemics so that primary care and management is very important in preventing expanded dengue syndrome.

Conclusion {#sec1-6}
==========

To conclude, the clinical profile of the dengue fever cases is changing in different epidemics, even in the same regions and with the period of time. Primary care physician should have a high index of suspicion to detect and timely manage the atypical manifestations of dengue fever as they are no more a rare entity and will continue to rise so long as they are looked for carefully in dengue patients. This study thus indicates the need for a continuous seroepidemiological surveillance for the early and definite identification of the clinical features and atypical manifestations of dengue infection.
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